drugset / Trial / NCT01799213

Discontinuing NSAIDs in Veterans With Knee Osteoarthritis

NCT01799213

Phase 2 Completed 490 enrolled VA Office of Research and Development
RandomizedParallel-groupTriple-blindTreatment

Summary

Knee osteoarthritis (OA) is now recognized as a major health problem. It is the number one cause of lower extremity disability and has significant deleterious effects on quality of life. While there are numerous therapies available for knee OA, most have limited efficacy. Of particular concern, is the widespread use of nonsteroidal anti-inflammatory drugs (NSAIDs) for this disorder. Veterans, as a group, are at high risk for both gastrointestinal and cardiovascular NSAID-induced complications. In this study the investigators propose to examine whether replacing NSAIDs with cognitive behavioral therapy delivered by telephone is an effective strategy for Veterans with knee OA. Telephone-administered therapy is particularly appealing since Veterans with knee OA are more likely to have limited mobility. If successful, this program may result in significant cost-savings for both Veterans (decreased co-pays and transportation costs) and the VA (decreased hospitalizations due to NSAID induced toxicity).

Timeline

Start
2013-09-02
Primary completion
2018-10-05
Completion
2018-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule 15 mg Oral

Indications